TrialJournal of attention disorders2024

A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD.

Vishal Madaan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.